|
1.
|
Bosch FX, Ribes J, Cléries R and Díaz M:
Epidemiology of hepatocellular carcinoma. Clin Liver Dis.
9:191–211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Xu P, Guo M and Hay BA: MicroRNAs and the
regulation of cell death. Trends Genet. 20:617–624. 2004.
View Article : Google Scholar
|
|
6.
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L,
Kipps T, Negrini M, Bullrich F and Croce CM: Frequent deletions and
downregulation of micro-RNA genes miR15 and miR16 at 13q14 in
chronic lymphocytic leukemia. Proc Natl Acad Sci USA.
99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Michael MZ, SM OC, van Holst Pellekaan NG,
Young GP and James RJ: Reduced accumulation of specific miRNAs in
colorectal neoplasia. Mol Cancer Res. 1:882–891. 2003.
|
|
8.
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
Mitsudomi T and Takahashi T: Reduced expression of the let-7 miRNAs
in human lung cancers in association with shortened postoperative
survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Borel F, Konstantinova P and Jansen PL:
Diagnostic and therapeutic potential of miRNA signatures in
patients with hepatocellular carcinoma. J Hepatol. 56:1371–1383.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kozaki KI and Inazawa J: Tumor-suppressive
microRNA silenced by tumor-specific DNA hypermethylation in cancer
cells. Cancer Sci. 103:837–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Zen K, Yasui K, Nakajima T, Zen Y, Zen K,
Gen Y, Mitsuyoshi H, Minami M, Mitsufuji S, Tanaka S, Itoh Y,
Nakanuma Y, Taniwaki M, Arii S, Okanoue T and Yoshikawa T: ERK5 is
a target for gene amplification at 17p11 and promotes cell growth
in hepatocellular carcinoma by regulating mitotic entry. Genes
Chromosomes Cancer. 48:109–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hatada I, Fukasawa M, Kimura M, Morita S,
Yamada K, Yoshikawa T, Yamanaka S, Endo C, Sakurada A, Sato M,
Kondo T, Horii A, Ushijima T and Sasaki H: Genome-wide profiling of
promoter methylation in human. Oncogene. 25:3059–3064. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Hatada I, Morita S, Kimura M, Horii T,
Yamashita R and Nakai K: Genome-wide demethylation during neural
differentiation of P19 embryonal carcinoma cells. J Hum Genet.
53:185–191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Hatada I, Namihira M, Morita S, Kimura M,
Horii T and Nakashima K: Astrocyte-specific genes are generally
demethylated in neural precursor cells prior to astrocytic
differentiation. PLoS One. 3:e31892008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Xiong Z and Laird PW: COBRA: a sensitive
and quantitative DNA methylation assay. Nucleic Acids Res.
25:2532–2534. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Dohi O, Takada H, Wakabayashi N, Yasui K,
Sakakura C, Mitsufuji S, Naito Y, Taniwaki M and Yoshikawa T:
Epigenetic silencing of RELN in gastric cancer. Int J Oncol.
36:85–92. 2010.PubMed/NCBI
|
|
17.
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kim YK and Kim VN: Processing of intronic
microRNAs. EMBO J. 26:775–783. 2007. View Article : Google Scholar
|
|
19.
|
Saini HK, Griffiths-Jones S and Enright
AJ: Genomic analysis of human microRNA transcripts. Proc Natl Acad
Sci USA. 104:17719–17724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tavazoie SF, Alarcon C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massague J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Png KJ, Yoshida M, Zhang XH, Shu W, Lee H,
Rimner A and Chan TA: MicroRNA-335 inhibits tumor reinitiation and
is silenced through genetic and epigenetic mechanisms in human
breast cancer. Genes Dev. 25:226–231. 2011. View Article : Google Scholar
|
|
22.
|
Scarola M, Schoeftner S, Schneider C and
Benetti R: miR-335 directly targets Rb1 (pRb/p105) in a proximal
connection to p53-dependent stress response. Cancer Res.
70:6925–6933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Tome M, Lopez-Romero P, Albo C, Sepulveda
JC, Fernandez-Gutierrez B, Dopazo A, Bernad A and Gonzalez MA:
miR-335 orchestrates cell proliferation, migration and
differentiation in human mesenchymal stem cells. Cell Death Differ.
18:985–995. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W,
Zhou Y, Ou Y, Lin X, Lin Y, Xu D, Zhou Y and Yan G: Targeting
oncogenic miR-335 inhibits growth and invasion of malignant
astrocytoma cells. Mol Cancer. 10:592011. View Article : Google Scholar : PubMed/NCBI
|
